brimonidine tartrate has been researched along with cgp 55845a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ananthalakshmi, KV; Edafiogho, IO; Kombian, SB | 1 |
Carey, MR; Regehr, WG | 1 |
2 other study(ies) available for brimonidine tartrate and cgp 55845a
Article | Year |
---|---|
Enaminones and norepinephrine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cyclohexanes; Dopamine; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; GABA Antagonists; In Vitro Techniques; Male; Neural Inhibition; Norepinephrine; Nucleus Accumbens; Phosphinic Acids; Prazosin; Propanolamines; Quinoxalines; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2006 |
Noradrenergic control of associative synaptic plasticity by selective modulation of instructive signals.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Animals, Newborn; Biophysics; Brimonidine Tartrate; Calcium; Calcium Signaling; Cerebellum; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glycine; In Vitro Techniques; Long-Term Synaptic Depression; Neural Pathways; Neuronal Plasticity; Norepinephrine; Patch-Clamp Techniques; Phosphinic Acids; Piperidines; Propanolamines; Purinergic P1 Receptor Antagonists; Purkinje Cells; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Synapses; Xanthines | 2009 |